Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Neurology Clinic, PC
mi
from
Cordova, TN
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Neurology Clinic, PC
mi
from
Cordova, TN
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Clinical Research Solutions
mi
from
Franklin, TN
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Clinical Research Solutions
mi
from
Franklin, TN
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Senior Adults Specialty Research
mi
from
Austin, TX
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Senior Adults Specialty Research
mi
from
Austin, TX
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Baylor College of Medicine
mi
from
Houston, TX
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Wasatch Clinical Research
mi
from
Salt Lake City, UT
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Wasatch Clinical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
VA Puget Sound-Alzhemier's Disease Research Center
mi
from
Seattle, WA
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
VA Puget Sound-Alzhemier's Disease Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Texas Neurology, PA
mi
from
Dallas, TX
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Texas Neurology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Neuropsychiatric Research Center of Southwest Florida
mi
from
Fort Myers, FL
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Neuropsychiatric Research Center of Southwest Florida
mi
from
Fort Myers, FL
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Meridien Research
mi
from
Saint Petersburg, FL
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Meridien Research
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Suncoast Neuroscience Associates Inc
mi
from
Saint Petersburg, FL
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Suncoast Neuroscience Associates Inc
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Saint Louis University Medical School /Department of Neurology & Psychiatry
mi
from
Saint Louis, MO
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Saint Louis University Medical School /Department of Neurology & Psychiatry
mi
from
Saint Louis, MO
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
Alzheimer's Research Corporation
mi
from
Manchester Township, NJ
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
Alzheimer's Research Corporation
mi
from
Manchester Township, NJ
Click here to add this to my saved trials
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated:  5/16/2017
The Neurocognitive Institute, LLC
mi
from
Mount Arlington, NJ
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension
Status: Enrolling
Updated: 5/16/2017
The Neurocognitive Institute, LLC
mi
from
Mount Arlington, NJ
Click here to add this to my saved trials
A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease
A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous and Subcutaneous RO7105705 Administered in Healthy Volunteers and Patients With Mild-to-Moderate Alzheimer's Disease
Status: Enrolling
Updated:  5/22/2017
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease
A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous and Subcutaneous RO7105705 Administered in Healthy Volunteers and Patients With Mild-to-Moderate Alzheimer's Disease
Status: Enrolling
Updated: 5/22/2017
New Orleans Center for Clinical Research
mi
from
Knoxville, TN
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US027
mi
from
Birmingham, AL
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US027
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US012
mi
from
Phoenix, AZ
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US012
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US024
mi
from
Little Rock, AR
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US024
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US053
mi
from
Glendale, CA
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US053
mi
from
Glendale, CA
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US023
mi
from
Imperial, CA
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US023
mi
from
Imperial, CA
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US015
mi
from
La Jolla, CA
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US015
mi
from
La Jolla, CA
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US045
mi
from
Long Beach, CA
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US045
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US002
mi
from
Los Angeles, CA
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US002
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US058
mi
from
San Francisco, CA
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US058
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US018
mi
from
Santa Ana, CA
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US018
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US060
mi
from
Denver, CO
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US060
mi
from
Denver, CO
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US042
mi
from
Boca Raton, FL
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US042
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US021
mi
from
Bradenton, FL
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US021
mi
from
Bradenton, FL
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US050
mi
from
Brooksville, FL
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US050
mi
from
Brooksville, FL
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US019
mi
from
Orlando, FL
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US019
mi
from
Orlando, FL
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US038
mi
from
Port Charlotte, FL
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US038
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US001
mi
from
West Palm Beach, FL
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US001
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US020
mi
from
Atlanta, GA
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US020
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US048
mi
from
Kailua, HI
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US048
mi
from
Kailua, HI
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US030
mi
from
Chicago, IL
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US030
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US051
mi
from
Joliet, IL
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US051
mi
from
Joliet, IL
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US040
mi
from
Indianapolis, IN
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US040
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US036
mi
from
Freeport, ME
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US036
mi
from
Freeport, ME
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US032
mi
from
Newton, MA
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US032
mi
from
Newton, MA
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US041
mi
from
Flowood, MS
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US041
mi
from
Flowood, MS
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US046
mi
from
Princeton, NJ
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US046
mi
from
Princeton, NJ
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US028
mi
from
Toms River, NJ
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US028
mi
from
Toms River, NJ
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US044
mi
from
Toms River, NJ
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US044
mi
from
Toms River, NJ
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US049
mi
from
Albany, NY
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US049
mi
from
Albany, NY
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US010
mi
from
Amherst, NY
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US010
mi
from
Amherst, NY
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US008
mi
from
New York, NY
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US008
mi
from
New York, NY
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US029
mi
from
New York, NY
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US029
mi
from
New York, NY
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US056
mi
from
New York, NY
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US056
mi
from
New York, NY
Click here to add this to my saved trials
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated:  5/30/2017
US037
mi
from
Orangeburg, NY
Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil
Status: Enrolling
Updated: 5/30/2017
US037
mi
from
Orangeburg, NY
Click here to add this to my saved trials